Inhibrx Biosciences (INBX) Shares Outstanding (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Shares Outstanding data on file, last reported at $14.6 million in Q4 2025.

• Shares Outstanding for Q4 2025 came in at $14.6 million, up 0.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.6 million (up 0.7% YoY), and the FY2025 annual result was $14.6 million, up 0.7% from the prior year.
• Shares Outstanding improved to $14.6 million in Q4 2025 per INBX's latest filing, from $14.5 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $49.2 million in Q1 2024 and troughed at $14.5 million in Q4 2024.
• A 3-year average of $26.3 million and a median of $14.5 million in 2025 frame the typical range for Shares Outstanding.
• On a YoY basis, Shares Outstanding climbed as much as 0.7% in 2025 and fell as far as 70.6% in 2025.
• A 3-year view of Shares Outstanding shows it stood at $47.4 million in 2023, then tumbled by 69.44% to $14.5 million in 2024, then grew by 0.7% to $14.6 million in 2025.
• Business Quant data shows INBX's Shares Outstanding at $14.6 million in Q4 2025, $14.5 million in Q3 2025, and $14.5 million in Q2 2025.